Steve Harr (Sana)

What’s it take to raise $700M-plus for a biotech start­up? Steve Harr has some thoughts on that

When Sana Biotech­nol­o­gy’s’ crew emerged from stealth mode to of­fi­cial­ly launch the com­pa­ny, no one said ex­act­ly how much mon­ey they had raised. With …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.